Artelo Biosciences (ARTL) Common Equity (2014 - 2025)
Artelo Biosciences' Common Equity was -$1.27 million in Q4 2025, compared with $2.86 million a year earlier.
Powered by 
Analysis
Artelo Biosciences (ARTL) Common Equity (2014 - 2025) Analysis & Trends
From Q4 2014 onward, Artelo Biosciences has reported Common Equity for 44 quarters.
- In earlier years, Common Equity was $2.86 million in FY2024 (-75.7%), $11.75 million in FY2023 (-39.4%), $19.4 million in FY2022 (-28.6%) and $27.17 million in FY2021.
- Quarterly Common Equity has moved between -$1.41 million (Q2 2025) and $25.78 million (Q1 2022) over five years.
- The best year-over-year quarter for Common Equity over five years was Q3 2021 (growth of 269.5%); the worst was Q1 2025 (a decline of 93.2%).
- Per Business Quant data, ARTL's Common Equity in the three quarters before Q4 2025 was -$633,000 (Q3 2025), -$1.41 million (Q2 2025) and $652,000 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Artelo Biosciences | 85,673.20 | -5.05 Mn | - | -1.27 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -1.27 Mn |
| Sep 30, 2025 | -633,000.00 |
| Jun 30, 2025 | -1.41 Mn |
| Mar 31, 2025 | 652,000.00 |
| Dec 31, 2024 | 2.86 Mn |
| Sep 30, 2024 | 6.36 Mn |
| Jun 30, 2024 | 7.30 Mn |
| Mar 31, 2024 | 9.54 Mn |
| Dec 31, 2023 | 11.75 Mn |
| Sep 30, 2023 | 14.58 Mn |
| Jun 30, 2023 | 16.27 Mn |
| Mar 31, 2023 | 17.64 Mn |
| Dec 31, 2022 | 19.40 Mn |
| Sep 30, 2022 | 21.90 Mn |
| Jun 30, 2022 | 23.84 Mn |
| Mar 31, 2022 | 25.78 Mn |
| Nov 30, 2021 | 28.29 Mn |
| Aug 31, 2021 | 12.04 Mn |
| May 31, 2021 | 11.92 Mn |
| Feb 28, 2021 | 12.86 Mn |
API Access
Artelo Biosciences Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=ARTL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "ARTL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=ARTL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();